A Ki67 index remaining above 10% after treatment can indicate that chemotherapy may not have had the desired benefit.

For example, a Ki67 index higher than 25% is often associated with a poorer prognosis in colorectal cancer.

The identifier refers to a specific Ki67 Antibody (Ki-67) produced by Santa Cruz Biotechnology (SCBT) . This antibody is a mouse monoclonal IgG1 κ widely used in laboratory research for the detection of the Ki67 protein, a primary marker for cell proliferation .

There is a direct correlation between the Ki67 index and the pathological grade of tumors.

For the most up-to-date technical details or to purchase this product, you can visit Santa Cruz Biotechnology or comparative sites like Biocompare . Ki67 Antibody (Ki-67) | SCBT - Santa Cruz Biotechnology